A Study of ABT-806 in Subjects With Advanced Solid Tumor Types
NCT01255657
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
ABT-806
Sponsor
AbbVie (prior sponsor, Abbott)